Merck & Co., Inc. announced the launch of a national print, television and online advertising campaign for the world's first cervical cancer vaccine, GARDASIL® [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine]. Adding to Merck's ongoing cervical cancer and HPV education efforts, the new campaign, called One Less, encourages females who are eligible for the vaccine to begin their vaccination series and to also continue to see their doctor for regular healthcare and screening.
- GARDASIL_Final_DTC_Release.pdf (24.17 KB)
Studies indicate that migrant and seasonal farmworkers often use herbal, home, or folk remedies instead of or simultaneously with conventional medical treatment. It is important to know when an herbal remedy should be discontinued, as well as those that need not be. Health care providers can gain substantial rapport with their patients by being open to the use of herbal remedies when appropriate. This resource is now over 20 years old, but much of the information is still relevant to current practice.
The Initiative's objective is to coordinate and optimize the availability of health resources for Mexican immigrants and their families through bilateral training, research, and health promotion activities.
Following the recent Food and Drug Administration (FDA) approval of a vaccine targeting cervical cancer, Women in Government, a national, bi-partisan, non-profit organization representing women state legislators, today recommended that all girls entering middle school be vaccinated against the human papillomavirus (HPV), the cause of cervical cancer. The recommendation is part of the group's new policy recommendations for the HPV vaccine's implementation in the states. The group also supports parental exemptions to the HPV vaccine, based on existing state immunization exemptions. The new HPV vaccine policy recommendations are part of Women in Government's "Challenge to Eliminate Cervical Cancer Campaign," which mobilizes state legislators to help eradicate cervical cancer through education and policy initiatives. Since 2004, 45 states have introduced legislation or resolutions tackling this issue.
The topic of this resource is Liver Cancer and Hep B and C. We present two articles in full and three abstracts on the issues.
- august06.pdf (107.41 KB)
In June 2005 and June 2006, the ACIP made policy changes for use of live, attenuated varicella containing vaccines for prevention of varicella.
- VaricellaACIPProvRecom082006.pdf (90.63 KB)
Preventionof Tetanus,Dhiphteria and Pertussis among pregnant women. ACIP voted on June 30, 2006.
- TdapPregnantACIPProvRecom062006.pdf (46.39 KB)
Produces "The Funletter," a national activities letter for kids and families living with cancer. Address: c/o Kenon Neal PO Box 4545 Santa Barbara, CA 93140
On May 16, 2006, the American Heart Association (AHA) and the American College of Cardiology (ACC) published guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease.
CDC released a revised interim Vaccine Information Statement (VIS) for Tdap vaccine. It is identical to the previous interim version except for minor changes in Section 3 that reflect ACIP's evolving recommendations regarding use of Tdap during pregnancy.
- vis-tdap_180706.pdf (52.58 KB)
Free cancer educational material from the National Cancer Institute
The June /July edition of the HepTalk Listserv will be devoted to Cultural Compentency. We're very pleased to welcome Dr. Jennie McLauren as the Listserv Editor for June 2006.
- junejuly06.pdf (33.9 KB)
A model project for binational tuberculosis control in the El Paso-Cuidad Juarez border region.
Between Women: provides support services, promote awareness and advocates throughout the community. This organization is the only one in California's Imperial Valley devoted exclusively to breast health.
New ACIP recommendations on HPV and Varicella vaccines. Update Mumps Outbreak.Influenza Season Update.
- IWJuly2006.doc (295 KB)
- VacunasBebes062006.pdf (45.03 KB)
- ImmxBabies062006.pdf (35.36 KB)
- Children_TeensVac062006.pdf (65.85 KB)
- VacunasNinos_Adolesc062006.pdf (85.32 KB)